Imaging study for dry age-related macular degeneration
Part of Eyes & vision clinical trials.
This study uses special eye scans and tests to look for blood vessel problems that may be linked to dry age-related macular degeneration (AMD). It might help find new ways to treat the condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 50 and 80 years old.
- You have dry AMD with geographic atrophy (a type of damage) in one eye, and the other eye is less affected.
- You are being treated at the Cole Eye Institute in Cleveland, Ohio.
- You do not have wet AMD or any fluid in the retina.
- You do not have other retinal diseases or have had vitreoretinal surgery.
- You do not have an allergy to iodine-based contrast dye or severe kidney disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses specialized eye imaging to track changes in geographic atrophy, a type of vision loss from macular degeneration. Researchers will use new imaging techniques to better understand how this condition progresses and how treatments work.
This study uses a special eye scan (OCT angiography) to look at new, abnormal blood vessel growth in people with wet age-related macular degeneration (wet AMD) who have not been treated yet. It may help researchers better understand the disease and how it changes over time.
This study observes how dry age-related macular degeneration (AMD) progresses over time. It helps doctors learn more about the disease, which may lead to better treatments in the future.
This study looks at how age-related macular degeneration (AMD) affects the light-sensitive part of the eye (retina) and the brain. By joining, you help researchers learn more about the condition, which could lead to better treatments in the future.
This study tests new ways to measure vision and take detailed eye images in people with age-related macular degeneration (AMD), a common eye condition affecting central vision. The goal is to develop better tools for future AMD treatment trials.
This study looks at how well the eyes function in people with early or intermediate age-related macular degeneration (AMD). It uses imaging and vision tests to help doctors better understand the condition.
Hear when a new Macular Degeneration trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.